| Term 
 | Definition 
 
        | •trade name: Prinivil •therapeutic class: Antihypertensive, treatment of heart failure •therapeutic use: Treatment of hypertension, heart failure, and improvement of survival in patients when administered within 24 hours after MI •pharmacologic class: ACE inhibitor •mechanism of action: Inhibits angiotensin converting enzyme, decreases aldosterone secretion |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | •trade name: Lopressor •therapeutic class: Antihypertensive, beta-blocker •therapeutic use: To slow progression of HF, & to significantly reduce the long-term consequences of HF •pharmacologic class: Selective beta1-adrenergic antagonist •mechanism of action: Decreases cardiac workload by reduction of heart rate (due to selective blockade of beta1-adrenergic receptors) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | •trade name: Primacor •therapeutic class: Positive inotrope •therapeutic use: Short-term treatment of advanced HF, to immediately increase myocardial contractility & cardiac output •pharmacologic class: Phosphodiesterase inhibitor •mechanism of action: Inhibits degradation of cAMP by phosphodiesterase |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | •trade name: Lasix •therapeutic class: Antihypertensive, treatment of edema & heart failure •therapeutic use: Treatment of acute heart failure, to remove edema, especially when cardiac output & renal flow are severely diminished •pharmacologic class: Loop diuretic •mechanism of action: Prevents renal reabsorption of sodium & chloride in the loop of Henle |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | •trade name: Digitek •therapeutic class: Positive inotrope •therapeutic use: To increase cardiac output, alleviating symptoms of heart failure & improving exercise tolerance •pharmacologic class: Cardiac glycoside •mechanism of action: Inhibits sodium-potassium ATPase, and increases intracellular calcium concentrations in cardiac cells |  | 
        |  |